LeMaitre Vascular, Inc. (NASDAQ:LMAT)
The Company is a medical device company that develops, manufactures and markets medical devices for the treatment of peripheral vascular disease.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
swr1111
(47.00)
Submitted: 12/5/2007 9:57:33 PM :
Start Price:
$6.54
LMAT Score:
-14.04
The biomedical giants are scrambling to find the next cash cow since the drug eluting stent market has been on a steady decline and is only now leveling out. Thus, LMAT and other smaller biomedical device companies with products outside the standard stenting arena are prime for purchase by the big guys.
Recs
razormd
(38.11)
Submitted: 9/24/2007 9:39:04 AM :
Start Price:
$6.48
LMAT Score:
-11.14
Worthy products for vascular surgery...revenues and profits steadily climbing...recent acuisition of Vascular Architects -- another respected private maker of vascular surgery devices -- will enhance market position and should become a strong positive long term although short term the merger might dampen profitability...2 bucks a share in cash and trading around $6-7 a share...looks pretty good for speculative money.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 2 of 2